China's Patience Will Beat US Threats in Latin America
If the US-China contest for influence over Latin America was a football match, China would be ahead of the US 2-1 at halftime.
While Donald Trump was busy making deals in the Middle East, his Chinese counterpart hosted Latin American leaders with investment and credit lines pledges, visa exemptions and proclamations of friendship and cooperation. Last week's summit between China and the CELAC forum, which groups 33 countries from Latin America and the Caribbean, saw the Asian giant in full charm mode, reassuring the region it's business as usual even if the US is trying to curb Chinese influence in the Americas. The contrast with the Trump White House's bellicosity toward the region — tariffs, deportations and sanctions included — couldn't be sharper.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Independent Non-Executive Director of Radiopharm Theranostics Picks Up 48% More Stock
Even if it's not a huge purchase, we think it was good to see that Ian Turner, the Independent Non-Executive Director of Radiopharm Theranostics Limited (ASX:RAD) recently shelled out AU$87k to buy stock, at AU$0.029 per share. That purchase might not be huge but it did increase their holding by 48%. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. The MD, CEO & Director Riccardo Canevari made the biggest insider purchase in the last 12 months. That single transaction was for AU$241k worth of shares at a price of AU$0.031 each. So it's clear an insider wanted to buy, even at a higher price than the current share price (being AU$0.024). It's very possible they regret the purchase, but it's more likely they are bullish about the company. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. In the last twelve months insiders purchased 22.43m shares for AU$772k. But insiders sold 1.50m shares worth AU$43k. Overall, Radiopharm Theranostics insiders were net buyers during the last year. Their average price was about AU$0.034. These transactions suggest that insiders have considered the current price attractive. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date! Check out our latest analysis for Radiopharm Theranostics Radiopharm Theranostics is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket. Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. From our data, it seems that Radiopharm Theranostics insiders own 11% of the company, worth about AU$6.3m. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing! It's certainly positive to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactions suggests that Radiopharm Theranostics insiders are expecting a bright future. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. When we did our research, we found 4 warning signs for Radiopharm Theranostics (2 make us uncomfortable!) that we believe deserve your full attention. But note: Radiopharm Theranostics may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Bloomberg
37 minutes ago
- Bloomberg
Trump Ups Metals Tariff to 50% to Aid Nippon-US Steel
Good morning. Steel and aluminum are set to face a 50% US tariff starting Wednesday. Australia homes are getting even more expensive. And next time you travel to Kyoto, make sure you go beyond the trends. Listen to the day's top stories. Steel and aluminum tariffs are back in focus. Donald Trump is boosting levies on the metals to 50% from 25%, saying the move will help protect American workers and benefit the operations of an expected deal between Nippon Steel and US Steel. Meanwhile, Treasury Secretary Scott Bessent said he's confident the latest trade clash between Trump and Xi Jinping ' will be ironed out ' in a call 'very soon.'
CNBC
43 minutes ago
- CNBC
Stock futures inch lower to kick off start of the new trading month: Live updates
A trader works on the floor of the New York Stock Exchange (NYSE) at the opening bell on May 30, 2025, in New York City. Angela Weiss | AFP | Getty Images Stock futures fell on Sunday as Wall Street looks to the start of a new month of trading following a strong performance in May. S&P 500 futures traded down 0.2%, while Nasdaq-100 futures dropped about 0.3%. Futures tied to the Dow Jones Industrial Average also declined 70 points, or 0.2%. On Friday, the S&P 500 closed out the month of May with a more than 6% gain, its best monthly performance since November 2023. The tech-heavy Nasdaq Composite surged more than 9% for the month and the Dow Jones Industrial Average rose about 4%. That said, Morgan Stanley's Chris Toomey is skeptical about whether May's market momentum will continue. "We're probably still range-bound," the managing director told CNBC's "Closing Bell" on Friday. "The concern we've got is that while I think we've taken [out] the worst-case scenario with regards to the 'liberation day' [tariffs], we're in a situation where I think the market's right now probably pricing in the best-case scenario." He added: "Everyone's talking about the fact that there's probably going to be 10% tariffs across the board, 30% for China. I think that's kind of baked in." President Donald Trump's tariffs have been in legal limbo following two key court rulings last week. The U.S. Court of International Trade struck down much of the president's steep levies Wednesday, ordering his administration to stop collecting them. A day later, however, a federal appeals court granted the administration's request to temporarily pause that ruling, effectively reinstating the duties. Trump's top economic advisors have remained optimistic in the tariffs even with the recent legal challenge, as Commerce Secretary Howard Lutnick said on Fox News over the weekend that the tariffs are "not going away." Additionally, National Economic Council Director Kevin Hassett told ABC News that he's "very confident that the judges will uphold this law." Hassett also suggested that Trump and China's President Xi Jinping could discuss trade as early as this week, though he said no date for the talks has been set. His comments come as trade tensions between the U.S. and China ramped up last week, with Trump writing in a Truth Social post Friday that China has "TOTALLY VIOLATED ITS AGREEMENT WITH US." Meanwhile, investors will be eyeing a slew of reports due this week that could provide insight into how tariffs have affected the U.S. economy, including the key May nonfarm payrolls reading on Friday. Stock futures traded lower Sunday evening. S&P 500 futures were down about 0.3% shortly after 6 p.m. ET, along with Nasdaq-100 futures. Futures tied to the Dow Jones Industrial Average fell 95 points, or 0.2%. — Sean Conlon
